The Association of Antenatal Steroids and Hypoglycemia in Preterm Neonates

John Ryan G. Viar, Elaine C. Cunanan

Jul 2021 DOI 10.35460/2546-1621.2020-0027     Access   

Abstract

Objective

Antenatal steroids have shown to decrease the rate of neonatal complications and morbidity; however, neonates are predisposed to significant hypoglycemia resulting in invasive interventions and prolonged nursery admissions. The risk of hypoglycemia in the preterm has been well studied, but the association of antenatal steroids and hypoglycemia in preterm neonates has not been well explored. Thus, we sought to determine the association of antenatal steroids given to mothers who delivered prematurely and the development of neonatal hypoglycemia.

Methods

A cross-sectional study using chart review was done on mother–preterm neonate pairs admitted in the charity obstetrical ward of The University of Santo Tomas Hospital from January 1, 2018 to December 31, 2019. The subjects were mothers either given or not given antenatal steroids before preterm delivery and their respective neonates. The provision of antenatal steroids was the primary exposure, while neonatal hypoglycemia was the primary outcome. Measurement of association was done using odds ratios. Univariate and multivariate logistic regression analyses were done.

Results

Of the 69 preterm neonates included in the study, hypoglycemia was observed in 14 neonates, among which 8 neonates were exposed to antenatal steroids. After examining the association using Fisher’s exact formula and controlling for potential confounders, neonatal hypoglycemia was not significantly higher among neonates exposed to antenatal steroids.

Conclusion

Antenatal steroids given to mothers who delivered preterm were not associated with the development of neonatal hypoglycemia. A prospective study model, larger population size and longer study coverage should be made to strengthen the outcome of the study.

  1. Beck S, Wojdyla D, Say L, Pilar Bertran A, Meraldi M, Harris Requejo J, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Org [Internet]. 2010 Jan 1;88(1):31–8. Available from: http://dx.doi.org/10.2471/BLT.08.062554

  2. Kuperstock J, Sung J, Taslimi M, Byrne J, El-Sayed Y, Langen E. Maternal glucose response to betamethasone administration. Amer J Perinatol [Internet]. 2014 Jun 10;30(2):143–8. Available from: http://dx.doi.org/10.1055/s-0034-1376387

  3. Pettit KE, Tran SH, Lee E, Caughey AB. The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia. The Journal of Maternal-Fetal & Neonatal Medicine [Internet]. 2013 Sep 5;27(7):683–6. Available from: http://dx.doi.org/10.3109/14767058.2013.832750

  4. Aydin M, Deveci U, Hakan N. Neonatal hypoglycemia associated with the antenatal corticosteroids may be secondary to fetal adrenal suppression. The Journal of Maternal-Fetal & Neonatal Medicine [Internet]. 2014 Jul 3;28(8):892–892. Available from: http://dx.doi.org/10.3109/14767058.2014.936002

  5. Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. The Journal of Pediatrics [Internet]. 2012 Nov;161(5):787–91. Available from: http://dx.doi.org/10.1016/j.jpeds.2012.05.022

  6. Voormolen DN, de Wit L, van Rijn BB, DeVries JH, Heringa MP, Franx A, et al. Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus. Dia Care [Internet]. 2018 Apr 13;41(7):1385–90. Available from: http://dx.doi.org/10.2337/dc18-0048

  7. Talmadge K, Philipson L, Reusch J, Hill-Briggs F, Youssef G, Bertha B, et al. Standards of medical care in diabetes-2018. American Diabetes Association Officers Chair Of The Board. 2018;150.

  8. Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2013 Nov 1;98(11):4227–49. Available from: http://dx.doi.org/10.1210/jc.2013-2465

  9. Kfouri J, D’Souza R. Antenatal corticosteroids. CMAJ [Internet]. 2017 Feb 26;189(8):E319–E319. Available from: http://dx.doi.org/10.1503/cmaj.160392

  10. Tas E, Garibaldi L, Muzumdar R. Glucose homeostasis in newborns: an endocrinology perspective. Neoreviews [Internet]. 2020 Jan;21(1):e14–29. Available from: http://dx.doi.org/10.1542/neo.21-1-e14

  11. Thompson-Branch A, Havranek T. Neonatal hypoglycemia. Pediatrics in Review [Internet]. 2017 Mar 31;38(4):147–57. Available from: http://dx.doi.org/10.1542/pir.2016-0063

  12. Brazy JE, Pupkin MJ. Effects of maternal isoxsuprine administration on preterm infants. The Journal of Pediatrics [Internet]. 1979 Mar;94(3):444–8. Available from: http://dx.doi.org/10.1016/s0022-3476(79)80599-5

  13. Epstein MF, Nicholls E, Stubblefield PG. Neonatal hypoglycemia after beta-sympathomimetic tocolytic therapy. The Journal of Pediatrics [Internet]. 1979 Mar;94(3):449–53. Available from: http://dx.doi.org/10.1016/s0022-3476(79)80600-9

  14. Procianoy RS, Pinheiro CEA. Neonatal hyperinsulinism after short-term maternal beta sympathomimetic therapy. The Journal of Pediatrics [Internet]. 1982 Oct;101(4):612–4. Available from: http://dx.doi.org/10.1016/s0022-3476(82)80722-1

  15. Begum S, Dey S, Fatema K. Neonatal glycemic status of infants of diabetic mothers in a tertiary care hospital. Indian J Endocr Metab [Internet]. 2018;22(5):621. Available from: http://dx.doi.org/10.4103/ijem.IJEM_689_17

  16. Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon K-H, et al. Diabetes in Asia. JAMA [Internet]. 2009 May 27;301(20):2129. Available from: http://dx.doi.org/10.1001/jama.2009.726

  17. World Health Organization. Global Report on Diabetes. Genève, Switzerland: World Health Organization; 2016.

  18. Skoll A, Boutin A, Bujold E, Burrows J, Crane J, Geary M, et al. No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes. Journal of Obstetrics and Gynaecology Canada [Internet]. 2018 Sep;40(9):1219–39. Available from: http://dx.doi.org/10.1016/j.jogc.2018.04.018

  19. Pintaudi B, Fresa R, Dalfrà M, Dodesini AR, Vitacolonna E, Tumminia A, et al. The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study. Acta Diabetol [Internet]. 2018 Sep 17;55(12):1261–73. Available from: http://dx.doi.org/10.1007/s00592-018-1208-x

Articles related to the one you are viewing

There are currently no results to show, please try again later

CC BY: Open Access Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/